Last reviewed · How we verify
Flax oil
Flax oil is a Dietary supplement / Nutraceutical Small molecule drug developed by University of Rochester. It is currently FDA-approved for Cardiovascular health support, Inflammatory condition adjunct. Also known as: Omega-3 Research Institute, Bethesda, MD.
Flax oil provides omega-3 and omega-6 polyunsaturated fatty acids that support cardiovascular and inflammatory health.
Flax oil, also known as linseed oil or flaxseed oil, is a colorless to yellowish oil obtained from the dried, ripened seeds of the flax plant. It has been studied in clinical trials for various conditions, including hypercholesterolemia, severe acute malnutrition in childhood, and dry eye syndrome, but its exact mechanism and efficacy are not specified in the available information.
At a glance
| Generic name | Flax oil |
|---|---|
| Also known as | Omega-3 Research Institute, Bethesda, MD |
| Sponsor | University of Rochester |
| Drug class | Dietary supplement / Nutraceutical |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular / Wellness |
| Phase | FDA-approved |
Mechanism of action
Flax oil is derived from flaxseeds and contains alpha-linolenic acid (ALA), an omega-3 fatty acid, along with linoleic acid (omega-6). These essential fatty acids are incorporated into cell membranes and serve as precursors for anti-inflammatory eicosanoids, potentially reducing systemic inflammation and supporting cardiovascular function.
Approved indications
- Cardiovascular health support
- Inflammatory condition adjunct
Common side effects
- Gastrointestinal upset
- Diarrhea
- Abdominal bloating
Key clinical trials
- Treatment of Severe Acute Malnutrition in Children 6 to 59 Months Old With Standard Ready To Use Therapeutic Food Compared to a Newly Formulated Lipid Optimized Ready To Use Therapeutic Food (NA)
- ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults (PHASE2)
- Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausal Women (NA)
- Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia (NA)
- Effects of Different Dietary Models on Eating Behavior and Obesity Management in Overweight and Obese Individuals (NA)
- The Effect of Alpha Linolenic Acid Intake on Patients With Elevated Glycemic Status (NA)
- Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes (NA)
- Acute Impact of Different Foods and Beverages on Exercise Induced Oxidative Stress and Inflammation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Flax oil CI brief — competitive landscape report
- Flax oil updates RSS · CI watch RSS
- University of Rochester portfolio CI
Frequently asked questions about Flax oil
What is Flax oil?
How does Flax oil work?
What is Flax oil used for?
Who makes Flax oil?
Is Flax oil also known as anything else?
What drug class is Flax oil in?
What development phase is Flax oil in?
What are the side effects of Flax oil?
Related
- Drug class: All Dietary supplement / Nutraceutical drugs
- Manufacturer: University of Rochester — full pipeline
- Therapeutic area: All drugs in Cardiovascular / Wellness
- Indication: Drugs for Cardiovascular health support
- Indication: Drugs for Inflammatory condition adjunct
- Also known as: Omega-3 Research Institute, Bethesda, MD
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing